Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 01, 2023

BUY
$108.61 - $118.38 $868 - $947
8 Added 0.21%
3,770 $435 Million
Q1 2023

Sep 01, 2023

BUY
$102.94 - $114.86 $823 - $918
8 Added 0.21%
3,762 $400 Million
Q4 2022

Sep 01, 2023

SELL
$87.44 - $112.11 $2,186 - $2,802
-25 Reduced 0.66%
3,754 $416 Million
Q3 2022

Sep 01, 2023

BUY
$84.53 - $94.96 $676 - $759
8 Added 0.21%
3,779 $325 Million
Q2 2022

Sep 01, 2023

BUY
$83.49 - $94.64 $834 - $946
10 Added 0.27%
3,771 $344 Million
Q1 2022

Sep 01, 2023

SELL
$73.51 - $82.4 $7,424 - $8,322
-101 Reduced 2.62%
3,761 $309 Million
Q4 2021

Sep 01, 2023

BUY
$72.28 - $90.54 $36,573 - $45,813
506 Added 15.08%
3,862 $296 Million
Q3 2021

Sep 01, 2023

SELL
$71.68 - $78.83 $1,576 - $1,734
-22 Reduced 0.65%
3,356 $252 Million
Q2 2021

Sep 01, 2023

SELL
$70.31 - $77.77 $38,178 - $42,229
-543 Reduced 13.85%
3,378 $263 Million
Q1 2021

Sep 01, 2023

BUY
$68.86 - $81.11 $4,200 - $4,947
61 Added 1.58%
3,921 $302 Million
Q4 2020

Sep 01, 2023

BUY
$71.77 - $79.65 $34,808 - $38,630
485 Added 14.37%
3,860 $316 Million
Q3 2020

Sep 01, 2023

BUY
$73.18 - $82.95 $8,196 - $9,290
112 Added 3.43%
3,375 $280 Million
Q2 2020

Sep 01, 2023

BUY
$70.42 - $80.13 $281 - $320
4 Added 0.12%
3,263 $252 Million
Q1 2020

Sep 01, 2023

BUY
$63.36 - $87.82 $316 - $439
5 Added 0.15%
3,259 $251 Million
Q4 2019

Sep 01, 2023

SELL
$77.58 - $87.54 $4,034 - $4,552
-52 Reduced 1.57%
3,254 $296 Million
Q3 2019

Sep 01, 2023

BUY
$76.08 - $82.93 $228 - $248
3 Added 0.09%
3,306 $278 Million
Q2 2019

Sep 01, 2023

SELL
$69.84 - $81.59 $48,678 - $56,868
-697 Reduced 17.42%
3,303 $277 Million
Q1 2019

Aug 31, 2023

BUY
$69.58 - $79.36 $278,320 - $317,440
4,000 New
4,000 $333 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Corrigan Financial, Inc. Portfolio

Follow Corrigan Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrigan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corrigan Financial, Inc. with notifications on news.